pyrroles has been researched along with Angioma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, JY; Kim, H; Kim, MJ; Lee, M; Lim, JS; Park, MS | 1 |
| Finlay, GA; Kwiatkowski, DJ; Malhowski, AJ; Malinowska-Kolodziej, I; Polizzi, K | 1 |
| Cagli, B; Intagliata, S; Onetti Muda, A; Perrone, G; Persichetti, P; Santini, D; Segreto, F; Tonini, G | 1 |
| Kilari, S; Miao, R; North, PE; Pan, J; Rahimi, N; Ramchandran, R; Remadevi, I; Wilkinson, GA; You, M; Zhao, B | 1 |
1 trial(s) available for pyrroles and Angioma
| Article | Year |
|---|---|
Endothelial cell-specific chemotaxis receptor (ECSCR) enhances vascular endothelial growth factor (VEGF) receptor-2/kinase insert domain receptor (KDR) activation and promotes proteolysis of internalized KDR.
Topics: Animals; Animals, Genetically Modified; Apoptosis Regulatory Proteins; Cell Line; Endosomes; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Female; Hemangioma; Human Umbilical Vein Endothelial Cells; Humans; Indoles; Male; Membrane Proteins; Placenta; Pregnancy; Protein Kinase Inhibitors; Proteolysis; Proto-Oncogene Proteins c-akt; Pyrroles; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2; Zebrafish | 2013 |
3 other study(ies) available for pyrroles and Angioma
| Article | Year |
|---|---|
Lack of anti-tumor activity by anti-VEGF treatments in hepatic hemangiomas.
Topics: Adult; Aged; Angiogenesis Inhibitors; Antineoplastic Agents; Bevacizumab; Female; Hemangioma; Humans; Indoles; Liver Neoplasms; Male; Middle Aged; Pyrroles; Sunitinib; Tomography, X-Ray Computed | 2016 |
Renal and liver tumors in Tsc2(+/-) mice, a model of tuberous sclerosis complex, do not respond to treatment with atorvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.
Topics: Animals; Atorvastatin; Cholesterol; Cystadenoma; Disease Models, Animal; Female; Hemangioma; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoenzyme Techniques; Kidney Neoplasms; Liver Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Pyrroles; Survival Rate; Tuberous Sclerosis; Tuberous Sclerosis Complex 2 Protein; Tumor Suppressor Proteins | 2009 |
Recurrent scrotal hemangiomas during treatment with sunitinib.
Topics: Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Diphosphonates; Genital Neoplasms, Male; Hemangioma; Humans; Imidazoles; Indoles; Kidney Neoplasms; Male; Middle Aged; Pyrroles; Recurrence; Scrotum; Skin Neoplasms; Sunitinib; Zoledronic Acid | 2010 |